Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

telesis bio inc - TBIO

TBIO

Close Chg Chg %
0.02 -0.02 -85.71%

Closed Market

0.00

-0.02 (85.71%)

Volume: 1.08K

Last Updated:

Dec 15, 2025, 3:37 PM EDT

Trade Now

Company Overview: telesis bio inc - TBIO

TBIO Key Data

Open

$0.00

 Day Range

0.00 - 0.00

52 Week Range

0.00 - 1.55

 Market Cap

$1.57M

Shares Outstanding

78.39M

 Public Float

76.91M

Beta

2.66

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$28.19

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

345.80

  

TBIO Performance

1 Week
 
 -85.71%
 
1 Month
 
 -85.71%
 
3 Months
 
 200.00%
 
1 Year
 
 -99.89%
 
5 Years
 
 N/A
 

TBIO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Telesis Bio Inc - TBIO

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
6.58M 11.04M 27.43M 27.51M
Sales Growth
+36.86% +67.93% +148.44% +0.27%
Cost of Goods Sold (COGS) incl D&A
17.17M 8.32M 14.71M 14.66M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.46M 1.57M 2.88M 4.10M
Depreciation
994.00K 1.12M 2.36M 3.59M
Amortization of Intangibles
463.00K 458.00K 515.00K 515.00K
COGS Growth
+93.21% -51.57% +76.91% -0.37%
Gross Income
(10.60M) 2.73M 12.72M 12.85M
Gross Income Growth
-159.50% +125.71% +366.79% +1.01%
Gross Profit Margin
-161.16% +24.68% +46.36% +46.70%
2020 2021 2022 2023 5-year trend
SG&A Expense
5.76M 38.10M 59.20M 48.00M
Research & Development
3.63M 14.55M 23.46M 17.50M
Other SG&A
2.14M 23.55M 35.74M 30.50M
SGA Growth
+99.27% +561.10% +55.40% -18.93%
Other Operating Expense
- - - -
-
Unusual Expense
880.00K 2.14M 719.00K 11.26M
EBIT after Unusual Expense
(17.24M) (37.51M) (47.20M) (46.41M)
Non Operating Income/Expense
(74.00K) (62.00K) (26.00K) 1.81M
Non-Operating Interest Income
- - - 1.74M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
690.00K 1.37M 1.22M 3.10M
Interest Expense Growth
-53.69% +98.41% -11.10% +155.14%
Gross Interest Expense
690.00K 1.37M 1.22M 3.10M
Interest Capitalized
- - - -
-
Pretax Income
(18.00M) (38.94M) (48.45M) (47.70M)
Pretax Income Growth
-116.88% -116.30% -24.40% +1.54%
Pretax Margin
-273.80% -352.66% -176.59% -173.40%
Income Tax
5.00K 14.00K 24.00K 24.00K
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(18.01M) (38.96M) (48.47M) (47.72M)
Minority Interest Expense
- - - -
-
Net Income
(18.01M) (38.96M) (48.47M) (47.72M)
Net Income Growth
-116.94% -116.31% -24.42% +1.54%
Net Margin Growth
-273.87% -352.78% -176.68% -173.49%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(18.01M) (38.96M) (48.47M) (47.72M)
Preferred Dividends
- - - 1.30M
-
Net Income Available to Common
(18.01M) (38.96M) (48.47M) (49.02M)
EPS (Basic)
-11.0911 -23.918 -29.6123 -29.5623
EPS (Basic) Growth
-116.94% -115.65% -23.81% +0.17%
Basic Shares Outstanding
1.62M 1.63M 1.64M 1.66M
EPS (Diluted)
-11.0911 -23.918 -29.6123 -29.5623
EPS (Diluted) Growth
-116.94% -115.65% -23.81% +0.17%
Diluted Shares Outstanding
1.62M 1.63M 1.64M 1.66M
EBITDA
(14.90M) (33.80M) (43.61M) (31.05M)
EBITDA Growth
-143.57% -126.78% -29.02% +28.81%
EBITDA Margin
-226.64% -306.08% -158.96% -112.86%

Telesis Bio Inc in the News